Markus Christian Gershater
Chief Tech/Sci/R&D Officer at Synthace Ltd.
Profile
Markus Christian Gershater is the founder of Synthace Ltd.
He previously worked as a Research Associate at University College London and as a Biotransformation Scientist at Novacta Biosystems Ltd.
He holds a doctorate degree from the University of Durham.
Markus Christian Gershater active positions
Companies | Position | Start |
---|---|---|
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 31/12/2010 |
Former positions of Markus Christian Gershater
Companies | Position | End |
---|---|---|
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
University College London | Corporate Officer/Principal | - |
Training of Markus Christian Gershater
University of Durham | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Technology Services |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Markus Christian Gershater